Select Page
FDA Approval: First Injectable PrEP for HIV

FDA Approval: First Injectable PrEP for HIV

The U.S. Food and Drug Administration (FDA) has given approval to start producing ViiV Healthcare’s cabotegavir, the first and only long-acting injectable pre-exposure prophylactic (PrEP) to reduce the risk of sexually acquired HIV-1. HIV-1 affects nearly 38 million...